(Q28118646)

Suppressor of cytokine signaling 3

GOA release 2020-03-11

1 reference

negative regulation of receptor signaling pathway via JAK-STAT

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

author name string

Gang Xu

1

1 reference

4 January 2017

Fang Yang

2

1 reference

4 January 2017

Cui-Ling Ding

3

1 reference

4 January 2017

Jing Wang

4

1 reference

4 January 2017

Ping Zhao

5

1 reference

4 January 2017

Wen Wang

6

1 reference

4 January 2017

Hao Ren

MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib

7

1 reference

4 January 2017

language of work or name

English

0 references

publication date

1 August 2014

1 reference

4 January 2017

1 reference

4 January 2017

462-463

1 reference

4 January 2017

343–350

1 reference

4 January 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

Increased microRNA-155 expression in the serum and peripheral monocytes in chronic HCV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

RISCy business: MicroRNAs, pathogenesis, and viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

Adaptive immune responses in acute and chronic hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

Hepatitis C Virus Proteins Modulate MicroRNA Expression and Chemosensitivity in Malignant Hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

miR-155 modulates microglia-mediated immune response by down-regulating SOCS-1 and promoting cytokine and nitric oxide production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

Liver-specific microRNA miR-122 enhances the replication of hepatitis C virus in nonhepatic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

Let-7b is a novel regulator of hepatitis C virus replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

Unscrambling hepatitis C virus-host interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

Identification of microRNAs specifically expressed in hepatitis C virus-associated hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

Evasion of intracellular host defence by hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

Hepatitis C virus blocks interferon effector function by inducing protein kinase R phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

miR221/222 in cancer: their role in tumor progression and response to therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

Alterations in microRNA expression profile in HCV-infected hepatoma cells: involvement of miR-491 in regulation of HCV replication via the PI3 kinase/Akt pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

Regulation of hepatitis C virus translation and infectious virus production by the microRNA miR-122

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

Treatment of HCV infection by targeting microRNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

MicroRNA in HCV infection and liver cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

Complete replication of hepatitis C virus in cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

Hepatitis C Virus Evasion from RIG-I-Dependent Hepatic Innate Immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

Hepatitis C virus core protein exerts an inhibitory effect on suppressor of cytokine signaling (SOCS)-1 gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

Porphyromonas gingivalis induction of microRNA-203 expression controls suppressor of cytokine signaling 3 in gingival epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

Abnormal B-cell activation associated with TALL-1 over-expression and SOCS-1 suppression during chronic hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

HepG2 cells expressing microRNA miR-122 support the entire hepatitis C virus life cycle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

microRNA involvement in hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

MicroRNA-155 is induced during the macrophage inflammatory response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

miR-221 silencing blocks hepatocellular carcinoma and promotes survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

miR-221 overexpression contributes to liver tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

miR-122 activates hepatitis C virus translation by a specialized mechanism requiring particular RNA components

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

Multifunction protein staphylococcal nuclease domain containing 1 (SND1) promotes tumor angiogenesis in human hepatocellular carcinoma through novel pathway that involves nuclear factor κB and miR-221

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

Dual Role of miR-122 in Molecular Pathogenesis of Viral Hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G(1) -modulated P53 activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

Computational analysis of microRNA-mediated antiviral defense in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

MicroRNA regulation of IFN-beta protein expression: rapid and sensitive modulation of the innate immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/β-catenin pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

Regulation of cytokine signaling by the SOCS and Spred family proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

Therapeutics Based on microRNA: A New Approach for Liver Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.06.024

10.1016/J.VIROL.2014.06.024

7 January 2021

Identifiers

DOI

0 references

Fatcat ID

release_qot2ze7eqnactczvgwmhznf4tm

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qot2ze7eqnactczvgwmhznf4tm